- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This 2006 book describes the clinical classification, underlying biological mechanisms and treatment of the myelodysplastic syndromes.
Andere Kunden interessierten sich auch für
- Recent Developments in Myelodysplastic Syndromes85,99 €
- Alan ListClinician¿s Manual on Myelodysplastic Syndromes38,99 €
- Myelodysplastic Syndromes74,99 €
- Diagnosis and Management of Myelodysplastic Syndromes75,99 €
- Diagnosis and Management of Myelodysplastic Syndromes103,99 €
- The Myelodysplastic Syndromes147,99 €
- Myelodysplastic Syndromes66,99 €
-
-
-
This 2006 book describes the clinical classification, underlying biological mechanisms and treatment of the myelodysplastic syndromes.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 336
- Erscheinungstermin: 25. November 2010
- Englisch
- Abmessung: 244mm x 170mm x 18mm
- Gewicht: 581g
- ISBN-13: 9780521182287
- ISBN-10: 052118228X
- Artikelnr.: 32731965
- Verlag: Cambridge University Press
- Seitenzahl: 336
- Erscheinungstermin: 25. November 2010
- Englisch
- Abmessung: 244mm x 170mm x 18mm
- Gewicht: 581g
- ISBN-13: 9780521182287
- ISBN-10: 052118228X
- Artikelnr.: 32731965
Preface Peter Greenberg; 1. Clinical and prognostic characterization of
Myelodysplastic Syndrome Peter Greenberg; 2. Morphologic classifications of
Myelodysplastic Syndrome: French-American-British and the World Health
Organization Richard Brunning; 3. Pathogenetic mechanisms underlying
Myelodysplastic Syndrome Peter Greenberg; 4. Cytogenetic abnormalities in
Myelodysplastic Syndrome Harold J. Olney and Michelle M. Le Beau; 5.
Molecular mechanisms and gene expression patterns in Myelodysplastic
Syndrome Wolf-Karsten Hofmann and Phillip Koeffler; 6. Immunologic
mechanisms and treatment of Myelodysplastic Syndrome A. John Barrett,
Elaine Sloand and Neal S. Young; 7. Biologically targeted therapies for
Myelodysplastic Syndrome Andrew Buresh and Alan List; 8. Supportive care in
Myelodysplastic Syndrome: hemopoietic cytokines and iron chelation therapy
Jason Gotlib and Peter Greenberg; 9. Hematopoietic cell transplantation
options in Myelodysplastic Syndrome Joachim Deeg and Bart Scott; 10.
Health-related quality of life in Myelodysplastic Syndrome:
conceptualization, measurement and implications Mary Thomas.
Myelodysplastic Syndrome Peter Greenberg; 2. Morphologic classifications of
Myelodysplastic Syndrome: French-American-British and the World Health
Organization Richard Brunning; 3. Pathogenetic mechanisms underlying
Myelodysplastic Syndrome Peter Greenberg; 4. Cytogenetic abnormalities in
Myelodysplastic Syndrome Harold J. Olney and Michelle M. Le Beau; 5.
Molecular mechanisms and gene expression patterns in Myelodysplastic
Syndrome Wolf-Karsten Hofmann and Phillip Koeffler; 6. Immunologic
mechanisms and treatment of Myelodysplastic Syndrome A. John Barrett,
Elaine Sloand and Neal S. Young; 7. Biologically targeted therapies for
Myelodysplastic Syndrome Andrew Buresh and Alan List; 8. Supportive care in
Myelodysplastic Syndrome: hemopoietic cytokines and iron chelation therapy
Jason Gotlib and Peter Greenberg; 9. Hematopoietic cell transplantation
options in Myelodysplastic Syndrome Joachim Deeg and Bart Scott; 10.
Health-related quality of life in Myelodysplastic Syndrome:
conceptualization, measurement and implications Mary Thomas.
Preface Peter Greenberg; 1. Clinical and prognostic characterization of
Myelodysplastic Syndrome Peter Greenberg; 2. Morphologic classifications of
Myelodysplastic Syndrome: French-American-British and the World Health
Organization Richard Brunning; 3. Pathogenetic mechanisms underlying
Myelodysplastic Syndrome Peter Greenberg; 4. Cytogenetic abnormalities in
Myelodysplastic Syndrome Harold J. Olney and Michelle M. Le Beau; 5.
Molecular mechanisms and gene expression patterns in Myelodysplastic
Syndrome Wolf-Karsten Hofmann and Phillip Koeffler; 6. Immunologic
mechanisms and treatment of Myelodysplastic Syndrome A. John Barrett,
Elaine Sloand and Neal S. Young; 7. Biologically targeted therapies for
Myelodysplastic Syndrome Andrew Buresh and Alan List; 8. Supportive care in
Myelodysplastic Syndrome: hemopoietic cytokines and iron chelation therapy
Jason Gotlib and Peter Greenberg; 9. Hematopoietic cell transplantation
options in Myelodysplastic Syndrome Joachim Deeg and Bart Scott; 10.
Health-related quality of life in Myelodysplastic Syndrome:
conceptualization, measurement and implications Mary Thomas.
Myelodysplastic Syndrome Peter Greenberg; 2. Morphologic classifications of
Myelodysplastic Syndrome: French-American-British and the World Health
Organization Richard Brunning; 3. Pathogenetic mechanisms underlying
Myelodysplastic Syndrome Peter Greenberg; 4. Cytogenetic abnormalities in
Myelodysplastic Syndrome Harold J. Olney and Michelle M. Le Beau; 5.
Molecular mechanisms and gene expression patterns in Myelodysplastic
Syndrome Wolf-Karsten Hofmann and Phillip Koeffler; 6. Immunologic
mechanisms and treatment of Myelodysplastic Syndrome A. John Barrett,
Elaine Sloand and Neal S. Young; 7. Biologically targeted therapies for
Myelodysplastic Syndrome Andrew Buresh and Alan List; 8. Supportive care in
Myelodysplastic Syndrome: hemopoietic cytokines and iron chelation therapy
Jason Gotlib and Peter Greenberg; 9. Hematopoietic cell transplantation
options in Myelodysplastic Syndrome Joachim Deeg and Bart Scott; 10.
Health-related quality of life in Myelodysplastic Syndrome:
conceptualization, measurement and implications Mary Thomas.